Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial
- PMID: 11105182
- DOI: 10.1001/jama.284.21.2755
Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial
Abstract
Context: High-dose chemotherapy poses considerable challenges to emesis management. Although prior studies suggest that acupuncture may reduce nausea and emesis, it is unclear whether such benefit comes from the nonspecific effects of attention and clinician-patient interaction.
Objective: To compare the effectiveness of electroacupuncture vs minimal needling and mock electrical stimulation or antiemetic medications alone in controlling emesis among patients undergoing a highly emetogenic chemotherapy regimen.
Design: Three-arm, parallel-group, randomized controlled trial conducted from March 1996 to December 1997, with a 5-day study period and a 9-day follow-up.
Setting: Oncology center at a university medical center.
Patients: One hundred four women (mean age, 46 years) with high-risk breast cancer.
Interventions: Patients were randomly assigned to receive low-frequency electroacupuncture at classic antiemetic acupuncture points once daily for 5 days (n = 37); minimal needling at control points with mock electrostimulation on the same schedule (n = 33); or no adjunct needling (n = 34). All patients received concurrent triple antiemetic pharmacotherapy and high-dose chemotherapy (cyclophosphamide, cisplatin, and carmustine).
Main outcome measures: Total number of emesis episodes occurring during the 5-day study period and the proportion of emesis-free days, compared among the 3 groups.
Results: The number of emesis episodes occurring during the 5 days was lower for patients receiving electroacupuncture compared with those receiving minimal needling or pharmacotherapy alone (median number of episodes, 5, 10, and 15, respectively; P<.001). The electroacupuncture group had fewer episodes of emesis than the minimal needling group (P<.001), whereas the minimal needling group had fewer episodes of emesis than the antiemetic pharmacotherapy alone group (P =.01). The differences among groups were not significant during the 9-day follow-up period (P =.18).
Conclusions: In this study of patients with breast cancer receiving high-dose chemotherapy, adjunct electroacupuncture was more effective in controlling emesis than minimal needling or antiemetic pharmacotherapy alone, although the observed effect had limited duration. JAMA. 2000;284:2755-2761.
Comment in
-
Methodological issues in trials of acupuncture.JAMA. 2001 Feb 28;285(8):1015-6; author reply 1016. doi: 10.1001/jama.285.8.1015. JAMA. 2001. PMID: 11209166 No abstract available.
-
Methodological issues in trials of acupuncture.JAMA. 2001 Feb 28;285(8):1016. JAMA. 2001. PMID: 11209167 No abstract available.
Similar articles
-
A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.J Oncol Pharm Pract. 2013 Jun;19(2):138-44. doi: 10.1177/1078155212457966. Epub 2012 Oct 3. J Oncol Pharm Pract. 2013. PMID: 23034405
-
Electroacupuncture for refractory acute emesis caused by chemotherapy.J Altern Complement Med. 2006 Dec;12(10):963-9. doi: 10.1089/acm.2006.12.963. J Altern Complement Med. 2006. PMID: 17212568 Clinical Trial.
-
Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.Support Care Cancer. 2003 Aug;11(8):516-21. doi: 10.1007/s00520-003-0467-3. Epub 2003 Jun 27. Support Care Cancer. 2003. PMID: 12836088 Clinical Trial.
-
[Research on antiemetics: an Italian model of success].Tumori. 1998 Jan-Feb;84(1 Suppl):S3-11. Tumori. 1998. PMID: 9617377 Review. Italian.
-
[Recent improvements in antiemetic therapy].Tumori. 1997;83(2 Suppl):S3-14. Tumori. 1997. PMID: 9235727 Review. Italian.
Cited by
-
Acupuncture for adult lung cancer of patient-reported outcomes: A systematic review and meta-analysis.Front Oncol. 2022 Sep 2;12:921151. doi: 10.3389/fonc.2022.921151. eCollection 2022. Front Oncol. 2022. PMID: 36119472 Free PMC article.
-
[Complementary medicines in oncology].Aten Primaria. 2007 Jan;39(1):5-6. doi: 10.1016/s0212-6567(07)70825-9. Aten Primaria. 2007. PMID: 17286916 Free PMC article. Review. Spanish. No abstract available.
-
Efficacy and safety of polydioxanone thread embedded at specific acupoints for non-specific chronic neck pain: a study protocol for a randomized, subject-assessor-blinded, sham-controlled pilot trial.Trials. 2018 Dec 6;19(1):672. doi: 10.1186/s13063-018-3058-9. Trials. 2018. PMID: 30522504 Free PMC article.
-
Use of Chinese medicine by cancer patients: a review of surveys.Chin Med. 2011 Jun 9;6:22. doi: 10.1186/1749-8546-6-22. Chin Med. 2011. PMID: 21651825 Free PMC article.
-
Electroacupuncture attenuates cerebral ischemia-reperfusion injury in diabetic mice through adiponectin receptor 1-mediated phosphorylation of GSK-3β.Mol Neurobiol. 2015 Apr;51(2):685-95. doi: 10.1007/s12035-014-8765-y. Epub 2014 Jun 11. Mol Neurobiol. 2015. PMID: 24915968
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical